Abstract: A miniature electric actuator for a high-integration vehicle sunshade roller blind is provided and relates to the technical field of sunshade roller blinds for vehicles. The technical features of the technical solution thereof are as follows: the electric actuator includes a driving motor (1), a roller blind synchronizing wheel (3) and a roller blind tube (5). A planetary reducer (2) is connected with an output end of the driving motor (1). The planetary reducer (2) is integrated inside the roller blind synchronizing wheel (3). A roller blind synchronizing inner tube (4) is fixedly connected with the output end of the planetary reducer (2). The roller blind synchronizing inner tube (4) is rotatably connected with the roller blind tube (5) by means of a bearing. A pre-tensioning spring (6) is disposed between the roller blind synchronizing inner tube (4) and the roller blind tube (5).

Abstract: A compact type dual-motor driving and force balance control device for roller blinds is provided. A left aluminum alloy support is fixedly disposed at one end of the roller blind spool, a left driving motor is fixedly disposed on one side of the left aluminum alloy support, a left driving output planetary reducer is fittingly disposed at an output end of the left driving motor, a left planetary reducer torque output shaft is fixedly disposed at one end of the left driving output planetary reducer, and a left connecting plate is fixedly disposed at one end of the left planetary reducer torque output shaft.

Abstract: A miniature high-reduction-ratio power device integrated within an outer rotor is provided, which includes a motor rotor, a rotor permanent magnet, a stator winding, a stator core, an internal fixing casing and an end cover. A primary sun gear is connected with a rotor output shaft of the motor rotor. Multiple primary planetary gears are meshed outside the primary sun gear, and a primary planetary gear carrier is connected with the primary planetary gears. A secondary sun gear is connected with the primary planetary gear carrier. Multiple secondary planetary gears are meshed outside the secondary sun gear, and the secondary planetary carrier is connected with the secondary planetary gears. A tertiary sun gear is connected with the secondary planetary carrier. Multiple tertiary planetary gears are meshed outside the tertiary sun gear, and a tertiary planetary carrier is connected with the multiple tertiary planetary gears.

Abstract: Disclosed is a method for a compound strengthening treatment of a gear surface, belonging to the technical field of gear surface treatment, including following steps: firstly, performing a compound shot peening treatment on the gear surface, and then performing molybdenum disulfide micro-particle thermal spraying on the obtained gear surface to complete the compound strengthening treatment on the gear surface.

Abstract: The present disclosure relates to a novel isolated binding protein including a N-terminal pro-brain natriuretic peptide (NT-proBNP) antigen binding domain, and the preparation method therefor. The antigen-binding domain includes at least one complementarity determining region selected from the amino acid sequences as defined in the present disclosure: or; has at least 80% sequence identity with the complementarity determining region of the following amino acid sequence and has an affinity of KD?2.26×10?8 to NT-proBNP. The binding protein may be used in the detection field of NT-proBNP protein.

Abstract: Provided is an anti-Plasmodium falciparum HRP-II antibody or an antigen-binding fragment thereof. The antibody comprises a heavy chain CDR1-3 shown in SEQ ID NO: 1-3 and a light chain CDR1-3 shown in SEQ ID NO: 4-6. Also provided are an application of the antibody and a method for preparing the antibody.

Abstract: Provided is an isolated binding protein including a Taq DNA polymerase antigen-binding domain. The antigen-binding domain includes at least one complementarity determining region selected from CDR-VH1-3 and CDR-VL1-3, or has at least 80% sequence identity with the complementarity determining region and has an affinity of KD?8.568×10?9 mol/L to the Taq DNA polymerase. The binding protein may be used in the field of molecular detection.

Abstract: Provided are an isolated binding protein including a pan-species-specific plasmodium lactate dehydrogenase antigen binding domain and a preparation method thereof. The antigen binding domain includes at least one complementarity determining region selected from a defined amino acid sequence, or has at least 80% of sequence identity with the complementarity determining region of the following amino acid sequence and an affinity of KD?1.5647×10?9 mol/L with a pan-species-specific plasmodium lactate dehydrogenase, and may identify the pan-species-specific plasmodium lactate dehydrogenase. The binding protein may be applied to the field of detection of plasmodium lactate dehydrogenase proteins.

Abstract: The present invention provides an isolated binding protein comprising a cTnI antigen binding domain. The antigen binding domain comprises at least one complementarity determining region selected from amino acid sequences defined herein, or has sequence identity of at least 80% to the complementarity determining region of said amino acid sequence and an affinity of KD?1.41×10?9 mol/L to cTnI. The binding protein can be used for detection of cTnI protein.

Abstract: A polypeptide having an amino acid sequence corresponding to a binding domain of a botulinum toxin is described. The polypeptide modulates expression of genes involved in, for example, collagen production and extra cellular matrix organization, and finds use, therefore in modulating skin quality attributes such as elasticity, firmness etc. Moreover, the polypeptide inhibits lipogenesis in specialized cells and finds use, therefore, in reducing skin oiliness, which is frequently observed in skin tissue afflicted with large pores and acne. Nucleic acids encoding the polypeptide, as well as vectors, host cells, and systems comprising the nucleic acids, are further described.

Abstract: A polypeptide having an amino acid sequence corresponding to a binding domain of a botulinum toxin is described. The polypeptide modulates expression of genes involved in, for example, collagen production and extra cellular matrix organization, and finds use, therefore in treating or reducing the occurrence of a disease such as a disease of the ECM, a connective or epithelial tissue disease, an endothelial disease or a fibrotic disease, e.g., a fibrotic disease of the ECM, connective tissue, or endothelium. Nucleic acids encoding the polypeptide, as well as vectors, host cells, and systems comprising the nucleic acids, are further described.

Abstract: A polypeptide having an amino acid sequence corresponding to a binding domain of a botulinum toxin is described. The polypeptide modulates expression of genes involved in, for example, collagen production and extra cellular matrix organization, and finds use, therefore in treating or reducing the occurrence of a disease such as a disease of the ECM, a connective or epithelial tissue disease, an endothelial disease or a fibrotic disease, e.g., a fibrotic disease of the ECM, connective tissue, or endothelium. Nucleic acids encoding the polypeptide, as well as vectors, host cells, and systems comprising the nucleic acids, are further described.

Abstract: A polypeptide having an amino acid sequence corresponding to a binding domain of a botulinum toxin is described. The polypeptide modulates expression of genes involved in, for example, collagen production and extra cellular matrix organization, and finds use, therefore in modulating skin quality attributes such as elasticity, firmness etc. Moreover, the polypeptide inhibits lipogenesis in specialized cells and finds use, therefore, in reducing skin oiliness, which is frequently observed in skin tissue afflicted with large pores and acne. Nucleic acids encoding the polypeptide, as well as vectors, host cells, and systems comprising the nucleic acids, are further described.